233 related articles for article (PubMed ID: 29121254)
1. Impact of donor and recipient human cytomegalovirus status on kidney transplantation.
Zielinski M; Tarasewicz A; Zielinska H; Jankowska M; Moszkowska G; Debska-Slizien A; Rutkowski B; Trzonkowski P
Int Immunol; 2017 Dec; 29(12):541-549. PubMed ID: 29121254
[TBL] [Abstract][Full Text] [Related]
2. Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
Meijers RW; Litjens NH; Hesselink DA; Langerak AW; Baan CC; Betjes MG
Am J Transplant; 2015 Dec; 15(12):3143-56. PubMed ID: 26211927
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
5. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
6. Impact of age and cytomegalovirus on CD8
Cantisán S; Páez-Vega A; Santos F; Rodríguez-Benot A; Aguado R; Rivero A; Montejo M; Torre-Cisneros J; Solana R;
Exp Gerontol; 2017 Sep; 95():98-106. PubMed ID: 28465043
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
Fleming T; Dunne J; Crowley B
J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
[TBL] [Abstract][Full Text] [Related]
8. CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients.
Zieliński M; Tarasewicz A; Zielińska H; Jankowska M; Moszkowska G; Dębska-Ślizień A; Rutkowski B; Trzonkowski P
J Clin Virol; 2016 Oct; 83():17-25. PubMed ID: 27526103
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
[TBL] [Abstract][Full Text] [Related]
10. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
Ishiyama K; Arakawa-Hoyt J; Aguilar OA; Damm I; Towfighi P; Sigdel T; Tamaki S; Babdor J; Spitzer MH; Reed EF; Sarwal MM; Lanier LL;
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181606
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G
J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105
[TBL] [Abstract][Full Text] [Related]
12. CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.
van der Heiden PLJ; van Egmond HM; Veld SAJ; van de Meent M; Eefting M; de Wreede LC; Halkes CJM; Falkenburg JHF; Marijt WAF; Jedema I
Transpl Immunol; 2018 Aug; 49():54-58. PubMed ID: 29679650
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.
Cantisán S; Torre-Cisneros J; Lara R; Rodríguez-Benot A; Santos F; Gutiérrez-Aroca J; Gayoso I; González-Padilla M; Casal M; Rivero A; Solana R
Clin Vaccine Immunol; 2009 Oct; 16(10):1429-38. PubMed ID: 19656991
[TBL] [Abstract][Full Text] [Related]
14. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
Schlott F; Steubl D; Hoffmann D; Matevossian E; Lutz J; Heemann U; Hösel V; Busch DH; Renders L; Neuenhahn M
PLoS One; 2017; 12(1):e0171035. PubMed ID: 28129395
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients.
Dornieden T; Wilde B; Korth J; Werner K; Horn PA; Witzke O; Lindemann M
J Immunol Res; 2019; 2019():3926175. PubMed ID: 30931336
[TBL] [Abstract][Full Text] [Related]
16. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
Schachtner T; Stein M; Reinke P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
[TBL] [Abstract][Full Text] [Related]
17. CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors.
Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Eason JD; Nouer SS; Sumida K; Remport A; Hall IE; Griffin R; Rofaiel G; Molnar MZ
Ren Fail; 2022 Dec; 44(1):831-841. PubMed ID: 35546431
[TBL] [Abstract][Full Text] [Related]
18. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
[TBL] [Abstract][Full Text] [Related]
19. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
20. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Front Immunol; 2018; 9():917. PubMed ID: 29867932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
